| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |